Edition:
United Kingdom

People: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

78.72USD
17 May 2019
Change (% chg)

$-0.41 (-0.52%)
Prev Close
$79.13
Open
$78.37
Day's High
$79.06
Day's Low
$77.87
Volume
2,696,348
Avg. Vol
3,450,838
52-wk High
$83.81
52-wk Low
$57.50

Frazier, Kenneth 

Mr. Kenneth C. Frazier is Chairman of the Board, President and Chief Executive Officer of the Company. Mr. Frazier previously served as Executive Vice President and President, Global Human Health of the Company (2009 to 2010) and Merck Sharp & Dohme Corp. (2007 to 2009). Mr. Frazier also served as Executive Vice President and General Counsel (2006 to 2007) of Merck Sharp & Dohme Corp. (formerly known as Merck & Co., Inc.). Director, Exxon Mobil Corporation since 2009 and Pharmaceutical Research and Manufacturers of America (PhRMA) since 2011. Trustee, The Pennsylvania State University and Cornerstone Christian Academy in Philadelphia, PA; Member, Board of Overseers of Weill Cornell Medical College and Graduate School of Medical Sciences, American Academy of Arts and Sciences, Council on Foreign Relations, the Council of the American Law Institute and the American Bar Association.

Basic Compensation

Total Annual Compensation, USD 4,258,790
Restricted Stock Award, USD 8,814,770
Long-Term Incentive Plans, USD --
All Other, USD 4,569,530
Fiscal Year Total, USD 17,643,100

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --